Labcorp Can't Score New Trial After $384M Patent Loss

By Andrew Karpan · February 12, 2025, 9:54 PM EST

Clinical lab giant Labcorp has failed to land a new trial in front of U.S. District Judge Alan Albright after a $384.4 million patent infringement judgment against it in a case...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

Ravgen, Inc. v. Laboratory Corporation of America Holdings

Case Number

Court

Texas Western

Nature of Suit

Patent

Date Filed

October 16, 2020

Recent Articles By Andrew

February 06, 2025
Drug Cos. Urge Full Fed. Circ. To Hear Teva Orange Book Row
January 08, 2025
Patent Board Knocks Out Most Of Apple Patent
January 08, 2025
Telligen's TM Suit Against IT Co. Can Move Forward
January 06, 2025
Labcorp Loses Appeal Of Gene-Testing Patent In $372M Case
December 04, 2024
Withers IP Partners Hop To Sullivan & Worcester
December 02, 2024
Judge Isn't Seeing 'Good Faith' Compliance In Probiotic Feud
November 22, 2024
Wellness Software Co. Not Immune From IP Suit, Judge Says
November 19, 2024
Judge Rejects Infosys' Bid To Seal NDAs In Trade Secrets Row
November 18, 2024
Melinta Obtains Ban On Generic Antibiotic Injections In IP Row
November 12, 2024
GOP Reps. Propose Another Bill On TRIPS Waivers